BioCryst Pharma (BCRX) Tops Q2 EPS by 1c; Sees Increase in Net Operating Cash

Go back to BioCryst Pharma (BCRX) Tops Q2 EPS by 1c; Sees Increase in Net Operating Cash
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.64 +0.21 (2.49%)
Previous Close $8.43    52 Week High $10.98 
Open $8.54    52 Week Low $1.63 
Day High $8.72    P/E N/A 
Day Low $8.43    EPS $-0.68 
Volume 2,206,935